Literature DB >> 1780714

Effect of low and ultra low oral doses of acetylsalicylic acid in microvascular surgery. An experimental study in the rabbit.

L Salemark1, J B Wieslander, P Dougan, B Arnljots.   

Abstract

About 10 h after administering acetylsalicylic acid (ASA) orally in doses of 4 mg and 20 micrograms/kg b.w., the central arteries of rabbit ears were subjected to severe vascular trauma (arteriotomy/intimectomy). Bleeding times from the trauma regions at reperfusion were measured and the activities from accumulating 32P-labelled homologous platelets recorded until 2 h after reperfusion when patencies were determined. In other studies, the effects of ASA on ex vivo platelet aggregation (aggregometry), thromboxane production, euglobulin clot lysis time and bleeding time following arterial puncture were investigated. Relative to controls, the following parameters were changed: patency was increased, as were the bleeding times following arterial puncture and thromboxane production was reduced. The median values of platelet accumulation were lower, but the changes were not statistically significant. Aggregometry showed decreased rates of platelet aggregability following treatment with ASA 4 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1780714     DOI: 10.3109/02844319109020620

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg Hand Surg        ISSN: 0284-4311


  3 in total

1.  Postoperative care and monitoring of the reconstructed head and neck patient.

Authors:  Christopher J Salgado; Harvey Chim; Shayla Schoenoff; Samir Mardini
Journal:  Semin Plast Surg       Date:  2010-08       Impact factor: 2.314

2.  Anticoagulative strategies in reconstructive surgery--clinical significance and applicability.

Authors:  Andreas Jokuszies; Christian Herold; Andreas D Niederbichler; Peter M Vogt
Journal:  Ger Med Sci       Date:  2012-01-17

3.  Testing a New Anticoagulation Method for Free Flap Reconstruction of Head and Neck Cancers.

Authors:  Ebrahim Karimi; Seyyed Hadi Samimi Ardestani; Mehrdad Jafari; Ali Bagheri Hagh
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-06-25       Impact factor: 3.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.